1. Home
  2. HIHO vs CVKD Comparison

HIHO vs CVKD Comparison

Compare HIHO & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIHO
  • CVKD
  • Stock Information
  • Founded
  • HIHO 1990
  • CVKD 2022
  • Country
  • HIHO Hong Kong
  • CVKD United States
  • Employees
  • HIHO N/A
  • CVKD N/A
  • Industry
  • HIHO Industrial Machinery/Components
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • HIHO Industrials
  • CVKD Health Care
  • Exchange
  • HIHO Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • HIHO 7.6M
  • CVKD 29.5M
  • IPO Year
  • HIHO 1996
  • CVKD 2023
  • Fundamental
  • Price
  • HIHO $1.70
  • CVKD $13.16
  • Analyst Decision
  • HIHO
  • CVKD Strong Buy
  • Analyst Count
  • HIHO 0
  • CVKD 1
  • Target Price
  • HIHO N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • HIHO 200.7K
  • CVKD 24.4K
  • Earning Date
  • HIHO 09-11-2025
  • CVKD 11-06-2025
  • Dividend Yield
  • HIHO 7.02%
  • CVKD N/A
  • EPS Growth
  • HIHO N/A
  • CVKD N/A
  • EPS
  • HIHO 0.01
  • CVKD N/A
  • Revenue
  • HIHO $7,080,000.00
  • CVKD N/A
  • Revenue This Year
  • HIHO N/A
  • CVKD N/A
  • Revenue Next Year
  • HIHO N/A
  • CVKD N/A
  • P/E Ratio
  • HIHO $177.06
  • CVKD N/A
  • Revenue Growth
  • HIHO 3.31
  • CVKD N/A
  • 52 Week Low
  • HIHO $1.40
  • CVKD $8.74
  • 52 Week High
  • HIHO $2.88
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • HIHO 51.96
  • CVKD 53.11
  • Support Level
  • HIHO $1.61
  • CVKD $12.50
  • Resistance Level
  • HIHO $1.77
  • CVKD $13.69
  • Average True Range (ATR)
  • HIHO 0.10
  • CVKD 0.57
  • MACD
  • HIHO -0.00
  • CVKD -0.06
  • Stochastic Oscillator
  • HIHO 31.86
  • CVKD 61.74

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: